Top ▲

TRPV3

Click here for help

Immunopharmacology Ligand target has curated data in GtoImmuPdb

Target id: 509

Nomenclature: TRPV3

Family: Transient Receptor Potential channels (TRP)

Gene and Protein Information Click here for help
Species TM P Loops AA Chromosomal Location Gene Symbol Gene Name Reference
Human 6 1 790 17p13.2 TRPV3 transient receptor potential cation channel subfamily V member 3 29,36
Mouse 6 1 791 11 45.25 cM Trpv3 transient receptor potential cation channel, subfamily V, member 3 26
Rat 6 1 791 10q24 Trpv3 transient receptor potential cation channel, subfamily V, member 3
Previous and Unofficial Names Click here for help
VRL3 | OLMS | transient receptor potential cation channel, subfamily V, member 3 | transient receptor potential cation channel
Database Links Click here for help
Alphafold
CATH/Gene3D
ChEMBL Target
DrugBank Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Orphanet
Pharos
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Associated Proteins Click here for help
Heteromeric Pore-forming Subunits
Name References
TRPV1 29
Auxiliary Subunits
Name References
Not determined
Other Associated Proteins
Name References
calmodulin 23,27,34
epidermal growth factor receptor 7
AKAP79 (AKAP-5) 38
Functional Characteristics Click here for help
γ = 197 pS at = +40 to +80 mV, 48 pS at negative potentials; conducts mono- and di-valent cations; outward rectification; potentiated by arachidonic acid
Ion Selectivity and Conductance Click here for help
Species:  Human
Rank order:  Ca2+ > Cs+ [172.0 pS] = K+ = Na+
References:  36
Ion Selectivity and Conductance Comments
The reported conductance (pS) for mouse TRPV3 is 201 at negative potentials and 147 at positive potentials [10].
TRPV3 unitary current amplitude is temperature dependent and increases with increasing temperature [10].
Voltage Dependence Click here for help
  V0.5 (mV)  τ (msec)  Reference  Cell type  Species 
Activation  - - Primary human keratinocytes, HEK-293 cells transfected with a human TRPV3 channel Human
Inactivation  - -
Comments  Gq-coupled receptor activation shifts TRPV3 voltage dependence of activation to less positive potentials in both primary human keratinocytes and transfected HEK-293 cells [13].
  V0.5 (mV)  τ (msec)  Reference  Cell type  Species 
Activation  80.7 – 144.0 - 8,34 HEK 293 cells transfected with the TRPV3 channel. Mouse
Inactivation  - -
Comments  Activation by two identical consecutive heat stimuli shifts V0.5 to less positive potential [8].
Other chemical activators (Human)
NO-mediated cysteine S-nitrosylation
Physical activators (Human)
depolarization (V½ ~ +80 mV, reduced to more negative values following heat stimuli), heat (23°C - 39°C, temperature threshold reduces with repeated heat challenge)

Download all structure-activity data for this target as a CSV file go icon to follow link

Activators
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Concentration range (M) Holding voltage (mV) Reference
vanillin Small molecule or natural product Ligand has a PDB structure Mm Activation - - 1x10-2 -80.0 – 80.0 35
Conc range: 1x10-2 M [35]
Holding voltage: -80.0 – 80.0 mV
Description: Two-electrode voltage-clamp
cinnamaldehyde Small molecule or natural product Click here for species-specific activity table Ligand has a PDB structure Mm Agonist - - 5x10-4 - 5x10-3 -80.0 – 80.0 21
Conc range: 5x10-4 - 5x10-3 M [21]
Holding voltage: -80.0 – 80.0 mV
carvacrol Small molecule or natural product Click here for species-specific activity table Ligand has a PDB structure Mm Full agonist - - 5x10-4 -80.0 – 80.0 35
Conc range: 5x10-4 M [35]
Holding voltage: -80.0 – 80.0 mV
Description: Patch clamp electrophysiology
citral Small molecule or natural product Ligand has a PDB structure Mm Activation 3.0 pKd - -100.0 – 100.0 30
pKd 3.0 (Kd 9.26x10-4 M) [30]
Holding voltage: -100.0 – 100.0 mV
Description: Patch clamp electrophysiology
farnesyl diphosphate Small molecule or natural product Mm Activation 6.9 pEC50 - - 2
pEC50 6.9 (EC50 1.3x10-7 M) Specifically activates TRPV3 among the tested TRP channels [2]
Description: Calcium imaging and patch clamp electrophysiology
cannabidiol Small molecule or natural product Approved drug Click here for species-specific activity table Ligand has a PDB structure Rn Activation 5.4 pEC50 - - 12
pEC50 5.4 (EC50 3.7x10-6 M) [12]
Description: Calcium imaging
tetrahydrocannabivarin Small molecule or natural product Ligand has a PDB structure Rn Activation 5.4 pEC50 - - 12
pEC50 5.4 (EC50 3.8x10-6 M) [12]
Description: Calcium imaging
KS0365 Small molecule or natural product Hs Activation 5.3 pEC50 - - 22
pEC50 5.3 (EC50 5.08x10-6 M) [22]
incensole acetate Small molecule or natural product Mm Activation 4.8 pEC50 - - 25
pEC50 4.8 (EC50 1.6x10-5 M) [25]
Description: Calcium imaging
2-APB Small molecule or natural product Click here for species-specific activity table Ligand has a PDB structure Mm Full agonist 4.6 pEC50 - -80.0 – 80.0 10
pEC50 4.6 (EC50 2.51x10-5 M) [10]
Holding voltage: -80.0 – 80.0 mV
Description: Patch clamp electrophysiology
diphenylboronic anhydride Small molecule or natural product Click here for species-specific activity table Mm Full agonist 4.1 – 4.2 pEC50 - -80.0 – 80.0 8
pEC50 4.1 – 4.2 (EC50 7.94x10-5 – 6.31x10-5 M) [8]
Holding voltage: -80.0 – 80.0 mV
Description: Patch clamp electrophysiology
6-tert-butyl-m-cresol Small molecule or natural product Mm Activation 3.4 pEC50 - - 33
pEC50 3.4 (EC50 3.7x10-4 M) [33]
Description: Two-electrode voltage-clamp
thymol Small molecule or natural product Ligand has a PDB structure Mm Full agonist 3.3 pEC50 - - 35
pEC50 3.3 [35]
Description: Patch clamp electrophysiology
dihydrocarveol Small molecule or natural product Mm Activation 2.6 pEC50 - - 33
pEC50 2.6 (EC50 2.57x10-3 M) [33]
Description: Two-electrode voltage-clamp
carveol Small molecule or natural product Mm Activation 2.5 pEC50 - - 33
pEC50 2.5 (EC50 3.03x10-3 M) [33]
eugenol Small molecule or natural product Click here for species-specific activity table Ligand has a PDB structure Mm Full agonist 2.5 pEC50 - - 35
pEC50 2.5 [35]
Description: Patch clamp electrophysiology
borneol Small molecule or natural product Mm Activation 2.5 pEC50 - - 33
pEC50 2.5 (EC50 3.45x10-3 M) [33]
Description: Two-electrode voltage-clamp
camphor Small molecule or natural product Click here for species-specific activity table Mm Full agonist 2.0 pEC50 - - 24
pEC50 2.0 [24]
Description: Patch clamp electrophysiology
(-)-menthol Small molecule or natural product Approved drug Click here for species-specific activity table Mm Activation 1.7 pEC50 - -80.0 – 80.0 21
pEC50 1.7 (EC50 1.995x10-2 M) [21]
Holding voltage: -80.0 – 80.0 mV
Description: Patch clamp electrophysiology and calcium imaging
View species-specific activator tables
Activator Comments
Chemical or thermal activation of TRPV3 evokes biphasic currents [8].
TRPV3 is also activated by innocuous heat [26,29,36].
Other monoterpenes including geraniol, linalool and propofol are reported to activate TRPV3 [33].
Sequentially applied high concentrations of diphenylboronic anhydride inhibit TRPV3 [8].
Antagonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
compound 74a [PMID: 27077528] Small molecule or natural product Primary target of this compound Hs Antagonist 6.4 pIC50 15
pIC50 6.4 (IC50 3.8x10-7 M) [15]
14-Deoxy-11,12-didehydroandrographolide Small molecule or natural product Immunopharmacology Ligand Hs Antagonist 6.1 pIC50 19
pIC50 6.1 (IC50 8x10-7 M) [19]
Description: Determined as inhibition of 2-APB channel activation in a fluorescent calcium assay; at +80 mV
Channel Blockers
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Concentration range (M) Holding voltage (mV) Reference
isopentenyl diphosphate Small molecule or natural product Click here for species-specific activity table Ligand has a PDB structure Hs Inhibition 6.6 pIC50 - - 3
pIC50 6.6 (IC50 2.39x10-7 M) [3]
Description: Calcium imaging
Trpvicin Small molecule or natural product Ligand has a PDB structure Hs Inhibition 6.4 pIC50 - - 14
pIC50 6.4 (IC50 3.8x10-7 M) [14]
aspirin-triggered resolvin D1 Small molecule or natural product Click here for species-specific activity table Immunopharmacology Ligand Hs Inhibition 6.4 pIC50 - - 4
pIC50 6.4 (IC50 3.98x10-7 M) [4]
Description: Calcium imaging
forsythoside B Small molecule or natural product Immunopharmacology Ligand Hs Inhibition 6.2 pIC50 - - 37
pIC50 6.2 (IC50 7x10-7 M) [37]
Isochlorogenic acid B Small molecule or natural product Hs Inhibition 6.1 pIC50 - - 28
pIC50 6.1 (IC50 9x10-7 M) [28]
ruthenium red Click here for species-specific activity table Mm Inhibition 6.0 pIC50 - - 26
pIC50 6.0 [26]
Description: Patch clamp electrophysiology
Isochlorogenic acid A Small molecule or natural product Hs Inhibition 5.6 pIC50 - - 28
pIC50 5.6 (IC50 2.7x10-6 M) [28]
diphenyltetrahydrofuran Small molecule or natural product Mm Antagonist 5.0 – 5.2 pIC50 - -80.0 – 80.0 8
pIC50 5.0 – 5.2 (IC50 1x10-8 – 6x10-9 M) [8]
Holding voltage: -80.0 – 80.0 mV
Description: Patch clamp electrophysiology
Citrusinine II Small molecule or natural product Click here for species-specific activity table Hs Inhibition 4.9 pIC50 - - 16
pIC50 4.9 (IC50 1.243x10-5 M) [16]
verbascoside Small molecule or natural product Hs Inhibition 4.8 pIC50 - - 31
pIC50 4.8 (IC50 1.41x10-5 M) [31]
osthole Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibition 4.4 pIC50 - - 32
pIC50 4.4 [32]
View species-specific channel blocker tables
Channel Blocker Comments
The value shown above for diphenyltetrahydrofuran represents action on initial current component [8].
Immunopharmacology Comments
TRPV3 is a thermosensitive cation channel that is expressed in keratinocytes. Selective TRPV3 inhibition is being investigated for therapeutic potential for treatment of chronic pruritus, skin allergy, or inflammation-related skin diseases.
Tissue Distribution Click here for help
Brain, spinal cord, dorsal root ganglia, skin, testes, stomach, trachea, small intestine, placenta, tongue, hair follicles, pituitary gland and adipose tissue.
Species:  Human
Technique:  In situ hybridisation, RT-PCR, northern blot, immunohistochemistry
References:  29,36
Skin keratinocytes, hair follicles, tongue and nasal epithelium
Species:  Mouse
Technique:  In situ hybridisation, northern blot, immunohistochemistry
References:  26,35
Skin
Species:  Rat
Technique:  Northern blot
References:  26
Functional Assays Click here for help
Patch clamp (whole-cell and single channel recordings) and calcium imaging.
Species:  Human
Tissue:  CHO-K1 anf HEK-293 cells transfected with a TRPV3 containing vector and human keratinocytes.
Response measured:  Activation by innocuous heat and/or chemical activator
References:  13,29,36
Patch clamp, two-electrode voltage-clamp and calcium imaging.
Species:  Mouse
Tissue:  CHO-K1 and HEK-293 cells transfected with a TRPV3 containing vector, mouse keratinocytes, mouse dorsal root ganglion neurons, 308 keratinocytes, Xenopus oocytes expressing mouse TRPV3.
Response measured:  Activation by innocuous heat, chemical activator and plant-derived substances.
References:  9-10,17,26,30,33,35
Physiological Functions Click here for help
Thermosensation, hair growth control
Species:  Human
Tissue:  Skin keratinocytes, hair follicles, sensory neurons
References:  5,29,36
Thermosensation (innocuous heat), detection and integration of innocuous and noxious stimuli (acute nociceptive pain), regulation of hair morphogenesis and skin barrier formation.
Species:  Mouse
Tissue:  Skin keratinocytes and sensory neurons.
References:  1,7,18,24,26
Physiological Consequences of Altering Gene Expression Click here for help
Keratinocyte specific TRPV3 transgenic mice show increased thermal nociception upon pharmacological inhibition of TRPV1.
Species:  Mouse
Tissue:  Skin
Technique:  Overexpression: TRPV3-YFP transgene expression under control of the keratin 14 promoter
References:  18
TRPV3 knockout mice show impaired thermosensation, display a wavy hair coat and curly whiskers and have dry and scaly skin.
Species:  Mouse
Tissue: 
Technique:  Gene knockout by homologous recombination (PMID: 15746429 and PMID: 20403327).
References:  7,24
Phenotypes, Alleles and Disease Models Click here for help Mouse data from MGI

Show »

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Trpv3tm1Apat Trpv3tm1Apat/Trpv3tm1Apat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
MGI:2181407  MP:0000367 abnormal coat/ hair morphology PMID: 15746429 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0009594 abnormal corneocyte envelope morphology PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0009594 abnormal corneocyte envelope morphology PMID: 20403327 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0001240 abnormal epidermis stratum corneum morphology PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0001240 abnormal epidermis stratum corneum morphology PMID: 20403327 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0000383 abnormal hair follicle orientation PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0000383 abnormal hair follicle orientation PMID: 20403327 
Trpv3+|Trpv3Nh Trpv3Nh/Trpv3+
DS
MGI:2181407  MP:0002073 abnormal hair growth PMID: 9250484 
Trpv3tm1Apat Trpv3tm1Apat/Trpv3tm1Apat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
MGI:2181407  MP:0003453 abnormal keratinocyte physiology PMID: 15746429 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0003453 abnormal keratinocyte physiology PMID: 20403327 
Trpv3tm1Apat Trpv3tm1Apat/Trpv3tm1Apat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
MGI:2181407  MP:0003663 abnormal thermosensation PMID: 15746429 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0001274 curly vibrissae PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
B6.129S4-Trpv3
MGI:2181407  MP:0001274 curly vibrissae PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0001274 curly vibrissae PMID: 20403327 
Trpv3+|Trpv3Nh Trpv3Nh/Trpv3+
DS
MGI:2181407  MP:0001194 dermatitis PMID: 9250484 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0003853 dry skin PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0003853 dry skin PMID: 20403327 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0003454 erythroderma PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0003454 erythroderma PMID: 20403327 
Trpv3+|Trpv3Nh Trpv3Nh/Trpv3+
DS
MGI:2181407  MP:0002412 increased susceptibility to bacterial infection PMID: 9250484 
Trpv3tm1Apat Trpv3tm1Apat/Trpv3tm1Apat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
MGI:2181407  MP:0001973 increased thermal nociceptive threshold PMID: 15746429 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0001192 scaly skin PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0001192 scaly skin PMID: 20403327 
Tg(KRT14-cre)1Amc|Trpv3tm1.1Clph Tg(KRT14-cre)1Amc/0,Trpv3tm1.1Clph/Trpv3tm1.1Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster
MGI:2181407  MGI:2450263  MP:0000410 waved hair PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
B6.129S4-Trpv3
MGI:2181407  MP:0000410 waved hair PMID: 20403327 
Trpv3tm1.2Clph Trpv3tm1.2Clph/Trpv3tm1.2Clph
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA
MGI:2181407  MP:0000410 waved hair PMID: 20403327 
Clinically-Relevant Mutations and Pathophysiology Click here for help
Disease:  Palmoplantar keratoderma, mutilating, with periorificial keratotic plaques
Synonyms: Olmsted syndrome
OMIM: 614594
Orphanet: ORPHA659
References:  20
Click column headers to sort
Type Species Amino acid change Nucleotide change Description Reference
Missense Human G573A 11
Missense Human G573S 20
Missense Human G573C 20
Missense Human W692G 20
Biologically Significant Variants Click here for help
Type:  Missense mutation
Species:  Mouse
Description:  A spontaneous G573C missense mutation in mice leads to dermatitis and hairlessness
Amino acid change:  G573C
References:  1
Type:  Missense mutation
Species:  Mouse
Description:  A spontaneous G573S missense mutation in mice leads to dermatitis and hairlessness
Amino acid change:  G573S
References:  1
General Comments
Broad et al. (2016) have published a review of TRPV3 in the drug discovery arena, and report the progress that has been made in TRPV3 antagonist development as novel drugs for the treatment of inflammatory skin conditions, itch and pain [6]. To date only one TRPV3 antagonist has been advanced to clinical trial: GRC15300 (structure not formally disclosed) was a compound designed by Glenmark Pharmaceuticals, and it was evaluated in a phase 2 study for the treatment of neuropathic pain. The GRC15300 programme has since has been discontinued.

References

Show »

1. Asakawa M, Yoshioka T, Matsutani T, Hikita I, Suzuki M, Oshima I, Tsukahara K, Arimura A, Horikawa T, Hirasawa T et al.. (2006) Association of a mutation in TRPV3 with defective hair growth in rodents. J Invest Dermatol, 126 (12): 2664-72. [PMID:16858425]

2. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. (2010) Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem, 285 (25): 19362-71. [PMID:20395302]

3. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. (2011) Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain, 152 (5): 1156-64. [PMID:21353389]

4. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. (2012) 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol, 165 (3): 683-92. [PMID:21718307]

5. Borbíró I, Lisztes E, Tóth BI, Czifra G, Oláh A, Szöllosi AG, Szentandrássy N, Nánási PP, Péter Z, Paus R et al.. (2011) Activation of transient receptor potential vanilloid-3 inhibits human hair growth. J Invest Dermatol, 131 (8): 1605-14. [PMID:21593771]

6. Broad LM, Mogg AJ, Eberle E, Tolley M, Li DL, Knopp KL. (2016) TRPV3 in Drug Development. Pharmaceuticals (Basel), 9 (3). [PMID:27618069]

7. Cheng X, Jin J, Hu L, Shen D, Dong XP, Samie MA, Knoff J, Eisinger B, Liu ML, Huang SM et al.. (2010) TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell, 141 (2): 331-43. [PMID:20403327]

8. Chung MK, Güler AD, Caterina MJ. (2005) Biphasic currents evoked by chemical or thermal activation of the heat-gated ion channel, TRPV3. J Biol Chem, 280 (16): 15928-41. [PMID:15722340]

9. Chung MK, Lee H, Caterina MJ. (2003) Warm temperatures activate TRPV4 in mouse 308 keratinocytes. J Biol Chem, 278 (34): 32037-46. [PMID:12783886]

10. Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. (2004) 2-aminoethoxydiphenyl borate activates and sensitizes the heat-gated ion channel TRPV3. J Neurosci, 24 (22): 5177-82. [PMID:15175387]

11. Danso-Abeam D, Zhang J, Dooley J, Staats KA, Van Eyck L, Van Brussel T, Zaman S, Hauben E, Van de Velde M, Morren MA et al.. (2013) Olmsted syndrome: exploration of the immunological phenotype. Orphanet J Rare Dis, 8: 79. [PMID:23692804]

12. De Petrocellis L, Orlando P, Moriello AS, Aviello G, Stott C, Izzo AA, Di Marzo V. (2012) Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol (Oxf), 204 (2): 255-66. [PMID:21726418]

13. Doerner JF, Hatt H, Ramsey IS. (2011) Voltage- and temperature-dependent activation of TRPV3 channels is potentiated by receptor-mediated PI(4,5)P2 hydrolysis. J Gen Physiol, 137 (3): 271-88. [PMID:21321070]

14. Fan J, Hu L, Yue Z, Liao D, Guo F, Ke H, Jiang D, Yang Y, Lei X. (2023) Structural basis of TRPV3 inhibition by an antagonist. Nat Chem Biol, 19 (1): 81-90. [PMID:36302896]

15. Gomtsyan A, Schmidt RG, Bayburt EK, Gfesser GA, Voight EA, Daanen JF, Schmidt DL, Cowart MD, Liu H, Altenbach RJ et al.. (2016) Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists. J Med Chem, 59 (10): 4926-47. [PMID:27077528]

16. Han Y, Luo A, Kamau PM, Takomthong P, Hu J, Boonyarat C, Luo L, Lai R. (2021) A plant-derived TRPV3 inhibitor suppresses pain and itch. Br J Pharmacol, 178 (7): 1669-1683. [PMID:33501656]

17. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD, Zhu MX. (2004) 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem, 279 (34): 35741-8. [PMID:15194687]

18. Huang SM, Lee H, Chung MK, Park U, Yu YY, Bradshaw HB, Coulombe PA, Walker JM, Caterina MJ. (2008) Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J Neurosci, 28 (51): 13727-37. [PMID:19091963]

19. Kalinovskii AP, Logashina YA, Palikova YA, Palikov VA, Osmakov DI, Mineev KS, Belozerova OA, Shmygarev VI, Kozlov SA, Dyachenko IA et al.. (2024) A Diterpenoid of the Medicinal Plant Andrographis paniculata Targets Cutaneous TRPV3 Channel and Relieves Itch. J Nat Prod, 87 (7): 1852-1859. [PMID:38961616]

20. Lin Z, Chen Q, Lee M, Cao X, Zhang J, Ma D, Chen L, Hu X, Wang H, Wang X et al.. (2012) Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet, 90 (3): 558-64. [PMID:22405088]

21. Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM. (2006) More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci, 32 (4): 335-43. [PMID:16829128]

22. Maier M, Olthoff S, Hill K, Zosel C, Magauer T, Wein LA, Schaefer M. (2022) KS0365, a novel activator of the transient receptor potential vanilloid 3 (TRPV3) channel, accelerates keratinocyte migration. Br J Pharmacol, 179 (24): 5290-5304. [PMID:35916168]

23. Mercado J, Gordon-Shaag A, Zagotta WN, Gordon SE. (2010) Ca2+-dependent desensitization of TRPV2 channels is mediated by hydrolysis of phosphatidylinositol 4,5-bisphosphate. J Neurosci, 30 (40): 13338-47. [PMID:20926660]

24. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, Andahazy M, Story GM, Patapoutian A. (2005) Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science, 307 (5714): 1468-72. [PMID:15746429]

25. Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E et al.. (2008) Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. FASEB J, 22 (8): 3024-34. [PMID:18492727]

26. Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, Story GM, Colley S, Hogenesch JB, McIntyre P et al.. (2002) A heat-sensitive TRP channel expressed in keratinocytes. Science, 296 (5575): 2046-9. [PMID:12016205]

27. Phelps CB, Wang RR, Choo SS, Gaudet R. (2010) Differential regulation of TRPV1, TRPV3, and TRPV4 sensitivity through a conserved binding site on the ankyrin repeat domain. J Biol Chem, 285 (1): 731-40. [PMID:19864432]

28. Qi H, Shi Y, Wu H, Niu C, Sun X, Wang K. (2022) Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus. Acta Pharm Sin B, 12 (2): 723-734. [PMID:35256942]

29. Smith GD, Gunthorpe MJ, Kelsell RE, Hayes PD, Reilly P, Facer P, Wright JE, Jerman JC, Walhin JP, Ooi L et al.. (2002) TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature, 418 (6894): 186-90. [PMID:12077606]

30. Stotz SC, Vriens J, Martyn D, Clardy J, Clapham DE. (2008) Citral sensing by Transient [corrected] receptor potential channels in dorsal root ganglion neurons. PLoS ONE, 3 (5): e2082. [PMID:18461159]

31. Sun X, Qi H, Wu H, Qu Y, Wang K. (2020) Anti-pruritic and anti-inflammatory effects of natural verbascoside through selective inhibition of temperature-sensitive Ca2+-permeable TRPV3 channel. J Dermatol Sci, 97 (3): 229-231. [PMID:31983608]

32. Sun XY, Sun LL, Qi H, Gao Q, Wang GX, Wei NN, Wang K. (2018) Antipruritic Effect of Natural Coumarin Osthole through Selective Inhibition of Thermosensitive TRPV3 Channel in the Skin. Mol Pharmacol, 94 (4): 1164-1173. [PMID:30108138]

33. Vogt-Eisele AK, Weber K, Sherkheli MA, Vielhaber G, Panten J, Gisselmann G, Hatt H. (2007) Monoterpenoid agonists of TRPV3. Br J Pharmacol, 151 (4): 530-40. [PMID:17420775]

34. Xiao R, Tang J, Wang C, Colton CK, Tian J, Zhu MX. (2008) Calcium plays a central role in the sensitization of TRPV3 channel to repetitive stimulations. J Biol Chem, 283 (10): 6162-74. [PMID:18178557]

35. Xu H, Delling M, Jun JC, Clapham DE. (2006) Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci, 9 (5): 628-35. [PMID:16617338]

36. Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, Ge P, Lilly J, Silos-Santiago I, Xie Y et al.. (2002) TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature, 418 (6894): 181-6. [PMID:12077604]

37. Zhang H, Sun X, Qi H, Ma Q, Zhou Q, Wang W, Wang K. (2019) Pharmacological Inhibition of the Temperature-Sensitive and Ca2+-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel by Natural Forsythoside B Attenuates Pruritus and Cytotoxicity of Keratinocytes. J Pharmacol Exp Ther, 368 (1): 21-31. [PMID:30377214]

38. Zhang X, Li L, McNaughton PA. (2008) Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron, 59 (3): 450-61. [PMID:18701070]

Contributors

Show »

How to cite this page